McKesson Co. (NYSE:MCK) Shares Acquired by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC increased its position in McKesson Co. (NYSE:MCKGet Rating) by 23.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,182 shares of the company’s stock after buying an additional 227 shares during the period. Chesley Taft & Associates LLC’s holdings in McKesson were worth $386,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Park National Corp OH raised its position in shares of McKesson by 4.8% in the second quarter. Park National Corp OH now owns 19,216 shares of the company’s stock valued at $6,268,000 after buying an additional 880 shares during the last quarter. American Trust raised its position in shares of McKesson by 119.3% in the first quarter. American Trust now owns 3,015 shares of the company’s stock valued at $923,000 after buying an additional 1,640 shares during the last quarter. Peachtree Investment Partners LLC acquired a new position in shares of McKesson in the first quarter valued at approximately $827,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of McKesson by 8.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,265 shares of the company’s stock valued at $8,346,000 after buying an additional 2,094 shares during the last quarter. Finally, Carlson Capital Management raised its position in shares of McKesson by 3.4% in the first quarter. Carlson Capital Management now owns 2,685 shares of the company’s stock valued at $822,000 after buying an additional 89 shares during the last quarter. Institutional investors and hedge funds own 86.43% of the company’s stock.

Analyst Upgrades and Downgrades

MCK has been the subject of several research analyst reports. Credit Suisse Group upped their price target on shares of McKesson from $377.00 to $385.00 and gave the stock an “outperform” rating in a research report on Monday, August 8th. Deutsche Bank Aktiengesellschaft upped their price target on shares of McKesson from $378.00 to $409.00 in a research report on Monday, August 8th. Morgan Stanley upped their price target on shares of McKesson from $370.00 to $403.00 and gave the stock an “overweight” rating in a research report on Monday, August 22nd. Argus upped their price target on shares of McKesson from $370.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, September 12th. Finally, Cowen upped their price target on shares of McKesson to $384.00 in a research report on Tuesday, August 9th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $352.46.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 1,300 shares of the stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $367.21, for a total transaction of $477,373.00. Following the transaction, the executive vice president now directly owns 2,544 shares in the company, valued at approximately $934,182.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other McKesson news, EVP Thomas L. Rodgers sold 1,300 shares of the stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $367.21, for a total transaction of $477,373.00. Following the sale, the executive vice president now directly owns 2,544 shares of the company’s stock, valued at $934,182.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Lori A. Schechter sold 7,500 shares of the stock in a transaction on Thursday, September 15th. The stock was sold at an average price of $343.94, for a total transaction of $2,579,550.00. Following the sale, the executive vice president now directly owns 11,678 shares in the company, valued at $4,016,531.32. The disclosure for this sale can be found here. Insiders have sold 10,335 shares of company stock worth $3,525,405 in the last ninety days. 0.21% of the stock is owned by insiders.

McKesson Trading Up 1.5 %

Shares of MCK stock opened at $346.25 on Friday. The company has a market capitalization of $49.77 billion, a PE ratio of 36.60, a price-to-earnings-growth ratio of 1.39 and a beta of 0.59. The firm has a fifty day simple moving average of $350.20 and a 200-day simple moving average of $326.31. McKesson Co. has a twelve month low of $193.89 and a twelve month high of $375.23.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Thursday, September 1st will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 0.62%. This is an increase from McKesson’s previous quarterly dividend of $0.47. The ex-dividend date is Wednesday, August 31st. McKesson’s dividend payout ratio is 22.83%.

About McKesson

(Get Rating)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.

Featured Stories

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.